FIVA - ETF AI Analysis
Top Page
Fidelity International High Dividend ETF (FIVA)
FIVA, the Fidelity International High Dividend ETF, earns a solid overall rating thanks to several strong global holdings with healthy finances and dependable dividends. Standout positions like Toyota, Novartis, ASML, and Nestlé contribute positively through robust earnings, solid balance sheets, and generally reasonable valuations, while names like Shell and Mitsubishi UFJ add income but face issues such as revenue or cash flow challenges. The main risk is that the fund is concentrated in a mix of financials, energy, and large industrial names, which can be sensitive to economic cycles and sector-specific downturns.
FIVA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 629.65M
- Region
- Developed Markets
- Expense Ratio
- 0.18%
- Beta
- 0.69
- Issuer
- Fidelity
- Inception Date
- Jan 16, 2018
- Dividend Yield
- 2.82%
- Asset Class
- Equity
- Index Tracked
- Fidelity International Value Factor Index
FIVA Summary
FIVA is the Fidelity International High Dividend ETF, built to follow the Fidelity International Value Factor Index. It focuses on international companies that pay relatively high dividends, aiming to provide both income and long-term growth. The fund holds well-known names like Nestlé, Toyota, ASML, and AstraZeneca, and spreads investments across many countries and sectors, which can help with diversification for a beginner investor. A key risk to remember is that stock prices and dividend payments can go up and down with global markets, so your investment value is not guaranteed.
How much will it cost me?
This ETF has an expense ratio of 0.18%, which means you’ll pay about $1.80 per year for every $1,000 you invest. That’s lower than the average stock ETF because it’s a passively managed fund that tracks an index rather than paying managers to pick individual stocks.
What would affect this ETF?
This ETF could benefit if developed markets outside the U.S. grow steadily, interest rates stabilize or fall (supporting dividend-paying financials and industrials), and global demand for products from companies like ASML, Nestlé, Toyota, and major banks remains strong. On the other hand, it could be hurt by rising interest rates that pressure high-dividend stocks, economic slowdowns in Europe or Japan, stricter banking or energy regulations, or weaker global trade that affects its financial, industrial, and energy holdings.
FIVA Top 10 Holdings
FIVA leans heavily on global blue chips, with ASML acting as a key engine of performance thanks to its rising year-to-date run, even if recent momentum has been mixed. Japanese names like Mitsubishi UFJ and KDDI add steady financial and telecom ballast, with KDDI quietly climbing. Big European healthcare players Roche and Novartis are helping on the margins, while AstraZeneca’s more mixed pattern and a lagging Nestlé are holding the fund back a bit. Overall, it’s a diversified, developed-markets ex-U.S. income play, not dominated by any single sector or country.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 2.68% | $16.88M | EUR 574.81B | 63.67% | 76Outperform |
 JP:8306 | Mitsubishi UFJ Financial Group | 1.69% | $10.65M | JPY 38.99T | 51.90% | 76Outperform |
 RHHVF | Roche Holding AG | 1.70% | $10.72M | $390.41B | 50.27% | ―― |
 CH:NESN | Nestlé SA | 1.52% | $9.57M | CHF 213.01B | 5.53% | 71Outperform |
 JP:7203 | Toyota Motor | 1.41% | $8.88M | JPY 36.44T | -2.19% | 80Outperform |
 GB:SHEL | Shell (UK) | 1.46% | $9.17M | GBP 229.46B | 40.43% | 73Outperform |
 TSE:TD | Toronto Dominion Bank | 1.49% | $9.38M | CAD 300.95B | 56.21% | 74Outperform |
 TSE:GIB.A | CGI | 1.38% | $8.66M | CAD 22.83B | -7.06% | 79Outperform |
 CH:NOVN | Novartis AG | 1.43% | $9.00M | CHF 242.18B | 34.31% | 80Outperform |
 SU | Suncor Energy | ― | ― | ― | ― | 77Outperform |
FIVA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FIVA, the sentiment is Positive. The current price of 38.30 is above the 20-day moving average (MA) of 37.95, below the 50-day MA of 38.75, and above the 200-day MA of 37.28, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 51.35 is Neutral, neither overbought nor oversold. The STOCH value of 65.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FIVA.
FIVA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FIVA | $38.30 | $42.00(9.66% Upside) | $629.65M | 0.18% | 68Neutral |
 FYLD | $40.30 | $43.92(8.98% Upside) | $751.58M | 0.59% | 62Neutral |
 TLTD | $100.53 | $117.61(16.99% Upside) | $660.70M | 0.39% | 65Neutral |
 TXUE | $34.82 | $39.82(14.37% Upside) | $579.64M | 0.65% | 64Neutral |
 MFDX | $41.34 | $50.62(22.46% Upside) | $452.32M | 0.39% | 64Neutral |
 AVSD | $79.49 | $92.39(16.23% Upside) | $375.49M | 0.23% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FIVA | Fidelity International High Dividend ETF | 38.30 | 7.53 | 24.46% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 40.30 | 10.32 | 34.43% | |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt | 100.53 | 14.44 | 16.77% | |
| TXUE | Thornburg International Equity ETF | 34.82 | 4.76 | 15.82% | |
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 41.34 | 5.32 | 14.77% | |
| AVSD | Avantis Responsible International Equity ETF | 79.49 | 9.52 | 13.60% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.